Transfection Reagents And Equipment Market

Bombardment equipment and particle acceleration have witnessed a reduction in the cost over the past years which will
boost its market penetration. This method is expected to grow at the fastest rate owing to increasing investment in order
to bring about technological innovations in this market.
Application Insights
Gene expression accounted for the largest share of revenue in 2016 as a result of larger use of the technology in this
segment. Vaccine biopharmaceuticals production requires substantial usage of gene expression methods based on the
principles of transfection.
Proteomic analyzers and cytology-based programs (for research purpose) are expected to witness demand in biomedical
and oncology studies. This factor is expected to fuel progress in the coming years.
Regional Insights
North American region witnessed highest penetration in 2016 owing to the presence of large number of research and
biopharmaceutical production institutes, biosimilar drugs, vaccines, and clinical organizations for R&D.
With the rise in number of academic institutes engaged in basic research for protein and genetic research which are
highly supported by the government, the market revenue for transfection is anticipated to witness potential increment.
Also, a large number of cancer research and specialized biomedical institute provides a platform for the development of
this technology.
Europe with respect to market share is close to North America and has gained significantly high revenue as per the
estimation. With favorable government policy, large-scale gene expression analysis is widely implemented in this region.
Also, large-scale development in reverse transfection has provided a strong base for penetration of the products in this
region.
Read Complete Report With TOC @ https://www.millioninsights.com/industry-reports/transfection-reagentsequipment-market
Asia-Pacific region is expected to witness fastest growth over the forecast period owing to progress in healthcare
infrastructure, for example, setting up of bio-incubators for research purpose, rise in government funding for basic
research held in academic institutions, increasing adoption of proteomics and cytological expression.
Competitive Insights
Roche, Promega and Life Technologies (a subsidiary of Thermo Fisher) are renowned players operating in this market.
These players are engaged in implementing strategic initiatives such as product development, diversification, vertical and
horizontal integration, and in some cases divestiture.
Other companies that are operating in this market are Lonza, Qiagen, Mirus Bio LLC, OriGene Technologies, EMD
Millipore, VWR International, BTX and SignaGen Laboratory.
Market Segment:
Transfection Reagent & Equipment Product Outlook (Revenue, USD Million, 2014 - 2022)
• Reagents
• Equipment
Transfection Reagent & Equipment Method Outlook (Revenue, USD Million, 2014 - 2022)